Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs
Many patients with ankylosing spondylitis (AS) could be treated with biologics – in particular, biologic disease-modifying antirheumatic drugs (DMARDs). However, this line of treatment is not efficacious nor well-tolerated…